• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal

This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more

• Alligator Bioscience: China Antibody Agreement with Biotheus (2019-08-20)
  Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that a license agreement has been reached with Biotheus Inc. (“Biotheus”), a privately held Chinese company based in Zhuhai, Guangdong, China. Under the license agreement, Alligator has granted Biotheu...
• Lundbeck Appoints Elise Hauge EVP, People & Communication (2019-08-14)
  H. Lundbeck A/S (Lundbeck) today announced the appointment of Elise Hauge to the role of EVP, People & Communication. Elise will join Lundbeck on 1 September 2019 and will be part of Executive Management. Elise will be responsible for driving Lundbeck’s people s...
• Novozyme’s CFO Prisca Havranek-Kosicek Leaves (2019-08-08)
  Novozymes A/S and Prisca Havranek-Kosicek have mutually agreed that she will discontinue her position as EVP and CFO with immediate effect. Jørgen Buhl Rasmussen, Chairman of the Board of Directors, and CEO Peder Holk Nielsen, comment: "Novozymes is the world...
• Cellink AB to Acquire Cytena GmbH for €30.25m (2019-08-05)
  The owners of Cytena GmbH ("Cytena") have agreed to sell all Cytena shares to CELLINK AB ("CELLINK") for a purchase price of 30.25M euros ("acquisition"). Through CELLINK’s complimentary technology offering cytena sees great synergies that will support and accelera...
• Janssen Returns Rights to CD40 Agonist Antibody to Alligator (2019-07-31)
  Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that it has regained exclusive, worldwide rights from Janssen Biotech Inc. to develop and commercialize the CD40 agonistic antibody, ADC-1013 (JNJ-64457107), its lead tumor-directed immunotherapy candi...
• Cytena GmbH Establishes Subsidiary in Taiwan (2019-07-23)
  Cytena, the specialist for single-cell technologies, is continuing its growth with the establishment of its subsidiary Cytena Bioprocess Solutions in Taiwan. Cytena Bioprocess Solutions is developing an innovative technology, which enables considerable reductions i...
• Medicxi Closes New €400m Fund (Medicxi III) (2019-07-19)
  > €400m Medicxi III fund, closed in just six weeks, and brings the total funds raised by Medicxi in the last three years to over $1b > Medicxi III will invest across the full healthcare continuum, from discovery to late stage clinical assets, empowering ambitiou...
• Genmab Raise $582m in US IPO at Nasdaq Global Select Market (2019-07-19)
  The 15% over-allotment option in connection with Genmab's initial public offering of American Depositary Shares in the United States and listing on the Nasdaq Global Select Market has been exercised in full Genmab A/S (CSE: GEN, Nasdaq: GMAB) announced today t...
• Genmab & Blink Biomedical Enter Commercial License Agreement (2019-07-12)
  Genmab and BliNK Biomedical have entered into a commercial license agreement to develop novel bispecific therapeutics based on BliNK Biomedical’s CD47 antibodies and Genmab’s DuoBody® Platform technology. Genmab A/S (Nasdaq Copenhagen: GEN) announced today tha...
• Nanoform Appoints Henri von Haarman as Director of IR (2019-07-10)
  Nanoform, an innovative medicine enabling nanotechnology company, has appointed Henri von Haartman as Director of Investor Relations. The newly created role will enrich investor relations as Nanoform seeks to further its shareholder base and continue its internatio...

Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!

[LSS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations


in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!

Start here with the latest News!

Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.